ABSTRACT:
Heterocyclic compounds show various potent biological activity. Every heterocyclic compound has different structure, different functional group and designed for different biological activities. Oxadiazole is one of those heterocyclic compounds possess various biological activity. The structure is simple contain carbon, nitrogen, oxygen, hydrogen. It shows various type of biological activities such as anti- convulsant, anti- microbial, anti- tumor, anti-helminth, anti- HIV, anti- Alzheimer, insecticidal, pesticidal, anti- inflammatory. This review gives a glance on oxadiazole compound, its different derivatives and its biological uses.
Cite this article:
Anuja S. Patil. Shrinivas K. Mohite. An Overview: 1, 3, 4- oxadiazole and its uses. Asian Journal of Research in Chemistry. 2021; 14(5):389-2. doi: 10.52711/0974-4150.2021.00066
Cite(Electronic):
Anuja S. Patil. Shrinivas K. Mohite. An Overview: 1, 3, 4- oxadiazole and its uses. Asian Journal of Research in Chemistry. 2021; 14(5):389-2. doi: 10.52711/0974-4150.2021.00066 Available on: https://ajrconline.org/AbstractView.aspx?PID=2021-14-5-15
REFERENCES:
1. P. Sengupta, M. Mal, S. Mandal, J. Singh, “Evaluation of antibacterial and antifungal activity of some 1,3,4- oxadiazole”. Iranian Journal of Pharmacology and Therapeutics, 2008; 7(2): 165-167.
2. N. Bhardwaj, S. K. Saraf, P. Kumar, “Synthesis, evaluation and Characterization of some 1, 3, 4- oxadiazole as antimicrobial agents”. E- Journal of Chemistry, 2009; 6(4): 1133-1138.
3. A. A. Kadi, N. R. El-Brollosy, O. A. Al-Deeb, E. E. Habib, T. M. Ibrahim, and A. A. El-Emam, “Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5substituted-1,3,4-thiadiazoles,” European Journal of Medicinal Chemistry, 2007; 42(2): 235-242.
4. V. Mickevi cius, R. Vaickelioniene, and B. Sapijanskaite, “Synthesis of substituted 1,3,4-oxadiazole derivatives,” Chemistry of Heterocyclic Compounds, 2009; 45(2): 215-218.
5. F. Bentiss and M. Lagrenee, “A new synthesis of symmetrical 2,5disubstituted 1,3,4-oxadiazoles,” Journal of Heterocyclic Chemistry, 1999; 36(4): 1029-1032.
6. S. Liras, M. P. Allen, and B. E. Segelstein, “A mild method for thepreparationof1,3,4-oxadiazoles: triflicanhydride promoted cyclization of diacylhydrazines”, Synthetic Communications, 2000; 30(3): 437-443.
7. D. Gomes, C. P. Borges, and J. C. Pinto, “Study of the synthesis of poly (4,4-diphenylether-1,3,4-oxadiazole) in solutions of poly (phosphoric acid),” Polymer, 2001; 42(3): 851-865.
8. A. Souldozi and A. Ramazani, “The reaction of (N-isocyanimino) triphenyl phosphorane with benzoic acid derivatives: a novel synthesis of 2-aryl-1,3,4-oxadiazole derivatives,” Tetrahedron Letters, 2007; 48(9): 1549-1551.
9. A. Ramazani, B. Abdian, F. Z. Nasrabadi, and M. Rouhani, “The reaction of N-isocyan iminotriphenyl phosphorane with biacetyl in the presence of (E)-cinnamic acids: synthesis of fully substituted1,3,4-oxadiazolederivativesviaintramolecular aza -Wittig reactions of in situ generated iminophosphoranes,” Phosphorus, Sulfuran Silicon and the Related Elements, 2013; 188(5): 642-648.
10. A. Ramazani, F. Zeinalia Nasrabadi, and Y. Ahmadi, “One-pot, four-component synthesis of fully substituted 1,3,4-oxadiazole derivatives from (Isocyanoimino) triphenyl phosphorane, a primary amine, an aromatic carboxylic acid, and chloroacetone,” Helvetica Chimica Acta, 2011; 94(6): 1024-1029.
11. A. Ramazani and A. Souldozi, “Iminophosphorane-mediated one-pot synthesis of 1,3,4-oxadiazole derivatives,” Arkivoc, 2008; 2008(16): 235-242.
12. R. Franski, “Biological activities of the compounds bearing 1,3,4-oxa(thia)diazole ring,” Asian Journal of Chemistry, 2005; 17(4): 2063-2075.
13. J. Parekhand, S. Chanda, “Invitro antimicrobial activity of Trapa natans L. fruit rind extracted in different solvents,” African Journal of Biotechnology, 2007; 6(6): 766-770.
14. X. Yao, M. Jericho, D. Pink, and T. Beveridge, “Thickness and elasticity of gram-negative murein sacculi measured by atomic force microscopy,” Journal of Bacteriology, 1999; 181(22): 6865-6875.
15. R. R. Somani, P. Y. Shirodkar, “Oxadiazole: A biologically important heterocycle”. Chem Inform, 2011; 42.
16. A. Zarghi, M. Faizi, B. Shafaghi, A. Ahadian, H. R. Khojastehpoor, “Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4oxadiazoles as benzodiazepine receptor agonists”. Bioorg Med Chem Letters 2015; 15: 3126-3129.
17. S. Botros, N. A. Khalil, B. H. Naguib, Y. El-Dash, “Synthesis and anticonvulsant activity of new phenytoin derivatives”. European Journal of Medicinal Chemistry, 2013; 60: 57-63.
18. M. A. Bhat, M. A. Al-Omar, N. Siddiqui, “Synthesis, anticonvulsant and neurotoxicity of some novel 1, 3, 4-oxadiazole derivatives of phthalimide”. Pharm Chem, 2010; 2: 1-10.
19. W. A. El-Sayed, F. A. El-Essawy, O.M. Ali, B. S. Nasr, M. M. Abdalla, “Anti-HIV activity of new substituted 1, 3, 4-oxadiazole derivatives and their acyclic nucleoside analogues”. Zeitschrift für Naturforschung C, 2009; 64: 773-778.
20. G. Şahin, E. Palaska, M. Ekizoğlu, M. Özalp, “Synthesis and antimicrobial activity of some 1, 3, 4-oxadiazole derivatives”. Il Farmaco, 2002; 57: 539-542.
21. U. Parimi, L. Pappu, “Synthesis and antimicrobial evaluation of imino substituted 1, 3, 4 oxa and thiadiazoles”. Int J Pharmacy Pharm Sci, 2012; 4: 523-527.
22. S. Cao, X. Qian, G. Song, Q. Huang, “Syntheses and insecticidal activity of new 2-(5-(trifluoromethyl) pyridyloxymethyl)-1, 3, 4-oxadiazoles”. Journal of Fluorine Chemistry, 2002; 117: 63-66.
23. Bansal S, Bala M, Suthar SK, Choudhary S, Bhattacharya S, “Design and synthesis of novel 2-phenyl-5-(1, 3-diphenyl-1H-pyrazol-4-yl)-1, 3, 4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity. European Journal of Medicinal Chemistry, 2014; 80: 167-174.
24. Husain A, Ajmal M Synthesis of novel 1, 3, 4-oxadiazole derivatives and their biological properties. Acta Pharmaceutica, 2009; 59: 223-233.
25. Dewangan D, Pandey A, Sivakumar T, Rajavel R, Dubey RD, “Synthesis of some novel 2, 5-disubstituted 1, 3, 4-oxadiazole and its analgesic, anti-inflammatory, anti-bacterial and anti-tubercular activity”. Int J Chem Tech Res, 2010; 2: 1397-1412.
26. Rane RA, Bangalore P, Borhade SD, Khandare PK, “Synthesis and evaluation of novel 4-nitropyrrole-based 1, 3, 4-oxadiazole derivatives as antimicrobial and anti-tubercular agents”. European Journal of Medicinal Chemistry, 2013; 70: 49-58.
27. Malhotra V, Pathak SR, Nath R, Mukherjee D, Shanker K, “Substituted imidazole derivatives as novel cardiovascular agents”. Bioorg Med Chem Letters, 2011; 21: 936-939.
28. G. R. Bankar, G.K. Nampurath, P. G. Nayak, S. Bhattacharya, “A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1, 3, 4-oxadiazole derivative, an L-type Ca 2+ channel blocker in deoxycorticosterone acetate and N G-nitro-l-arginine hypertensive rats”. Chemico-biological interactions, 2010; 183: 327-331.
29. K. Patel, J. Chandran, R. Shah, J. Vijaya, G. Sreenivasa, “Synthesis, characterization and anthelmintic activity (Perituma posthuman) of new oxadiazole incorporated with imidazole and pyrazole”. Int J Pharm Bio Sci, 2010; 1: 1-13.
30. C. Cheptea, V. Şunel, M. Holban, J. Desbrieres, M. Popa, “Enhanced antipyretic activity of new 2, 5-substituted 1, 3, 4-oxadiazoles encapsulated in alginate/gelatin particulate systems”. Cellulose Chemistry and Technology, 2012; 46: 19.
31. M. Saitoh, J. Kunitomo, E. Kimura, Y. Hayase, H. Kobayashi, “Design, synthesis and structure–activity relationships of 1, 3, 4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β. Bioorg Med Chem, 2009; 17: 2017-2029